Fracture risk among treatment-naïve postmenopausal women with osteopenia in Greece: results from the “ACROSS” study
Sign Up to like & getrecommendations! Published in 2020 at "Archives of Osteoporosis"
DOI: 10.1007/s11657-020-00837-x
Abstract: Summary Use of the FRAX (Fracture Risk Assessment Tool) tool to assess fracture risk is the most common practice worldwide. Our findings suggest that in treatment-naïve women with osteopenia treatment would be cost-effective for approximately… read more here.
Keywords: risk; treatment; study; fracture risk ... See more keywords
Zoledronate prevents fractures in osteopenia
Sign Up to like & getrecommendations! Published in 2018 at "Nature Reviews Endocrinology"
DOI: 10.1038/s41574-018-0116-z
Abstract: Nature reviews | E n d o c r i n o l o g y Original article Reid, I. R. et al. Fracture prevention with zoledronate in older women with osteopenia. N. Engl. J.… read more here.
Keywords: fragility; zoledronate; preventing fractures; group ... See more keywords
Effect of Ginseng Extracts on the Improvement of Osteopathic and Arthritis Symptoms in Women with Osteopenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Sign Up to like & getrecommendations! Published in 2021 at "Nutrients"
DOI: 10.3390/nu13103352
Abstract: Ginsenosides are active compounds that are beneficial to bone metabolism and have anti-osteoporosis properties. However, very few clinical investigations have investigated the effect of ginseng extract (GE) on bone metabolism. This study aims to determine… read more here.
Keywords: group; effect; bone; arthritis symptoms ... See more keywords
In older postmenopausal women with osteopenia, zoledronate reduced fragility fractures at 6 years
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Internal Medicine"
DOI: 10.7326/acpj201904160-042
Abstract: Question In postmenopausal women with osteopenia, does zoledronate reduce fragility fractures? Methods Design Randomized placebo-controlled trial. ACTRN12609000593235. Allocation {Concealed}*. Blinding Blinded (patients and trial staff). Follow-up period 6 years. Setting Auckland region of New Zealand.… read more here.
Keywords: zoledronate; fragility; fracture; women osteopenia ... See more keywords